Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |